Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program.

Combinations of beta-lactams plus aminoglycosides have been standard therapy for suspected infections in granulocytopenic cancer patients, especially those with profound long-lasting granulocytopenia. With the advent of new broad-spectrum bactericidal antibiotics such as extended-spectrum cephalospo...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Antimicrob Agents Chemother
المؤلفون الرئيسيون:	Cometta, A, Calandra, T, Gaya, H, Zinner, S H, de Bock, R, Del Favero, A, Bucaneve, G, Crokaert, F, Kern, W V, Klastersky, J, Langenaeken, I, Micozzi, A, Padmos, A, Paesmans, M, Viscoli, C, Glauser, M P
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	American Society for Microbiology (ASM) 1996
الموضوعات:	Research Article
الوصول للمادة أونلاين:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163274/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8723449/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.5.1108
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة